Bonhomme V, Boveroux P, Brichant J F, Laureys S, Boly M
University Department of Anesthesia and ICM, CHR Citadelle, Liege, Belgium.
Arch Ital Biol. 2012 Jun-Sep;150(2-3):155-63. doi: 10.4449/aib.v150i2.1242.
This paper reviews the current knowledge about the mechanisms of anesthesia-induced alteration of consciousness. It is now evident that hypnotic anesthetic agents have specific brain targets whose function is hierarchically altered in a dose-dependent manner. Higher order networks, thought to be involved in mental content generation, as well as sub-cortical networks involved in thalamic activity regulation seems to be affected first by increasing concentrations of hypnotic agents that enhance inhibitory neurotransmission. Lower order sensory networks are preserved, including thalamo-cortical connectivity into those networks, even at concentrations that suppress responsiveness, but cross-modal sensory interactions are inhibited. Thalamo-cortical connectivity into the consciousness networks decreases with increasing concentrations of those agents, and is transformed into an anti-correlated activity between the thalamus and the cortex for the deepest levels of sedation, when the subject is non responsive. Future will tell us whether these brain function alterations are also observed with hypnotic agents that mainly inhibit excitatory neurotransmission. The link between the observations made using fMRI and the identified biochemical targets of hypnotic anesthetic agents still remains to be identified.
本文综述了目前关于麻醉诱导意识改变机制的知识。现在很明显,催眠性麻醉剂具有特定的脑靶点,其功能会以剂量依赖的方式分级改变。被认为参与心理内容生成的高阶网络以及参与丘脑活动调节的皮质下网络似乎首先会受到催眠剂浓度增加的影响,这些催眠剂会增强抑制性神经传递。低阶感觉网络得以保留,包括这些网络中的丘脑 - 皮质连接,即使在抑制反应性的浓度下也是如此,但跨模态感觉相互作用会受到抑制。随着这些药物浓度的增加,丘脑 - 皮质与意识网络的连接会减少,并且在深度镇静的最深水平,即受试者无反应时,会转变为丘脑和皮质之间的反相关活动。未来将告诉我们,在主要抑制兴奋性神经传递的催眠剂中是否也会观察到这些脑功能改变。使用功能磁共振成像(fMRI)所做的观察与已确定的催眠性麻醉剂生化靶点之间的联系仍有待确定。